Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[SERM--selective estrogen receptor modulators].

K B Kønig1, P A Eiken, P Schwarz

  • 1Medicinsk afdeling F, Amtssygehuset i Gentofte.

Ugeskrift for Laeger
|May 3, 2001
PubMed
Summary

Selective estrogen receptor modulators (SERMs) treat estrogen receptor-positive breast cancer. Recent advancements suggest SERMs may indicate new therapeutic applications for various diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Excitation Spectra of the ^{12}C(p,d) Reaction near the η^{'}-Meson Emission Threshold Measured in Coincidence with High-Momentum Protons.

Physical review letters·2026
Same author

Sarcopenia and self-reported markers of physical frailty in patients with osteoporosis.

Archives of osteoporosis·2024
Same author

Clinical practice guidelines for perioperative care in bariatric surgery 2023: Adapted ERAS (enhanced recovery after surgery) guidelines with consensual voting of the working group of the Joint Bariatric and Metabolic Surgery Section of the Czech Surgery….

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2024
Same author

Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
Same author

New options for surgeons to improve malnutrition in the outpatient setting.

Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti·2021
Same author

Prevalence of muscle dysfunction concomitant with osteoporosis in a home-dwelling Danish population aged 65-93 years - The Copenhagen Sarcopenia Study.

Experimental gerontology·2020

Area of Science:

  • Pharmacology
  • Oncology
  • Endocrinology

Context:

  • Selective Estrogen Receptor Modulators (SERMs) are a class of drugs targeting estrogen-sensitive tissues.
  • SERMs are primarily recognized for their efficacy in treating estrogen receptor-positive breast cancer.

Purpose:

  • To explore the expanding therapeutic landscape of SERMs beyond breast cancer treatment.
  • To highlight recent developments and clinical trials investigating new applications for SERMs.

Summary:

  • Recent advancements in the development and clinical trials of Selective Estrogen Receptor Modulators (SERMs) are uncovering novel indications.
  • These studies suggest that SERMs may become valuable treatments for a broader range of diseases.
  • The research focuses on leveraging the tissue-specific activity of SERMs for diverse therapeutic goals.

Impact:

  • This research broadens the potential clinical utility of SERMs.
  • It may lead to new treatment options for patients with various conditions.
  • The findings underscore the versatility of SERMs in medicinal chemistry and clinical practice.

Related Experiment Videos